No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs182864046 |
chr8:10617924-10617925 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs533360983 |
chr8:10617941-10617942 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs117161187 |
chr8:10617943-10617944 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs569809338 |
chr8:10617990-10617991 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs535662143 |
chr8:10618050-10618051 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs185728404 |
chr8:10618052-10618053 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs142339160 |
chr8:10618070-10618071 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs534455263 |
chr8:10618175-10618176 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs919555 |
chr8:10618176-10618177 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs577223618 |
chr8:10618183-10618184 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs78492292 |
chr8:10618189-10618190 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs4841440 |
chr8:10618200-10618201 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs576630361 |
chr8:10618201-10618202 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs542484321 |
chr8:10618203-10618204 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs562175780 |
chr8:10618228-10618229 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs112200833 |
chr8:10618237-10618238 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs572589896 |
chr8:10618266-10618267 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs541585744 |
chr8:10618267-10618268 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs564523306 |
chr8:10618269-10618270 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs533373214 |
chr8:10618283-10618284 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs375031239 |
chr8:10618285-10618286 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs73542560 |
chr8:10618314-10618315 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs563679581 |
chr8:10618365-10618366 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs529207116 |
chr8:10618462-10618463 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs151269646 |
chr8:10618477-10618478 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs565785763 |
chr8:10618489-10618490 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs541877183 |
chr8:10618503-10618504 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs528227391 |
chr8:10618513-10618514 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs371957924 |
chr8:10618532-10618533 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs376779792 |
chr8:10618553-10618554 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs570977981 |
chr8:10618556-10618557 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs140512169 |
chr8:10618570-10618571 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs191574979 |
chr8:10618577-10618578 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs182977542 |
chr8:10618597-10618598 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs535810184 |
chr8:10618609-10618610 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs556021654 |
chr8:10618631-10618632 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs572680664 |
chr8:10618642-10618643 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs34771714 |
chr8:10618655-10618656 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs541596152 |
chr8:10618656-10618657 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs558297316 |
chr8:10618670-10618671 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs578164203 |
chr8:10618766-10618767 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs75643352 |
chr8:10618770-10618771 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs187973888 |
chr8:10618778-10618779 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs529287759 |
chr8:10618795-10618796 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs79699709 |
chr8:10618805-10618806 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs190727420 |
chr8:10618842-10618843 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs138386547 |
chr8:10618851-10618852 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs551131293 |
chr8:10618852-10618853 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs77974131 |
chr8:10618862-10618863 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs76410058 |
chr8:10618870-10618871 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|